Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Aliaga A., Kostikov A., Maclaren D. A., Clark S. D., Bedard M. A. (2014). PET imaging with [(1)(8)F]fluoroethoxybenzovesamicol ([(1)(8)F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat, Nucl Med Biol, 41(1), 96-101. En savoir plus.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Clark S. D., Aghourian M., Bedard M. A. (2014). Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [F]fluoroethoxybenzovesamicol, Behav Brain Res, 278C, 107-114. En savoir plus.

Gauthier S., Leuzy A., Rosa-Neto P. (2014). How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?, Neurodegener Dis, 13(2-3), 197-9. En savoir plus.

Kim D., Kim R. G., Kim H. S., Kim J. M., Jun S. C., Lee B., Jo H. J., Rosa-Neto P., Lee M. C., Kim H. I. (2014). Longitudinal changes in resting-state brain activity in a capsular infarct model, J Cereb Blood Flow Metab. En savoir plus.

Kim H. S., Kim D., Kim R. G., Kim J. M., Chung E., Rosa-Neto P., Lee M. C., Kim H. I. (2014). A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study, J Cereb Blood Flow Metab, 34(4), 683-9. En savoir plus.

Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. En savoir plus.

Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. En savoir plus.

Milella M. S., Marengo L., Larcher K., Fotros A., Dagher A., Rosa-Neto P., Benkelfat C., Leyton M. (2014). Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study, NeuroImage, 98, 195-202. En savoir plus.

Ongali B., Nicolakakis N., Tong X. K., Aboulkassim T., Papadopoulos P., Rosa-Neto P., Lecrux C., Imboden H., Hamel E. (2014). Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model, Neurobiol Dis, 68, 126-36. En savoir plus.

Wu L., Soder R. B., Schoemaker D., Carbonnell F., Sziklas V., Rowley J., Mohades S., Fonov V., Bellec P., Dagher A., Shmuel A., Jia J., Gauthier S., Rosa-Neto P. (2014). Resting state executive control network adaptations in amnestic mild cognitive impairment, J Alzheimers Dis, 40(4), 993-1004. En savoir plus.

Zimmer E. R., Leuzy A., Benedet A. L., Breitner J., Gauthier S., Rosa-Neto P. (2014). Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging, J Neuroinflammation, 11, 120. En savoir plus.

Zimmer E. R., Leuzy A., Bhat V., Gauthier S., Rosa-Neto P. (2014). In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals, Transl Neurodegener, 3(1), 6. En savoir plus.

Zimmer E. R., Leuzy A., Gauthier S., Rosa-Neto P. (2014). Developments in Tau PET Imaging, Can J Neurol Sci, 41(5), 547-53. En savoir plus.

Zimmer E. R., Parent M. J., Cuello A. C., Gauthier S., Rosa-Neto P. (2014). MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research, Trends Neurosci. En savoir plus.